Surveillance, Epidemiology, and End Results Program

A program of the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI) to collect data on all forms of cancer, including myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone marrow does not work well, and the bone marrow cells fail to make enough healthy blood cells. Myelo refers to the bone marrow. Dysplastic means abnormal growth or development. People with MDS have low blood cell count for at… (MDS). In 2001, SEER began collecting data on the incidence and survival of people with MDS. Incidence refers to the number of new cases diagnosed each year.

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.